SCHEMBL17606206

SCHEMBL17606206

O=C(O)N(CC1(O)CCN(Cc2ccccc2)C1)C1CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.51
CHRM3 P20309 4/20 0.51
OPRM1 P35372 2/20 0.50
OPRL1 P41146 1/20 0.45
POLB P06746 1/20 0.44
CYP2D6 P10635 2/20 0.44
CHRM4 P08173 1/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
DRD2 P14416 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
SIGMAR1 Q99720 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17606580 0.92 CHRM2 (0.56) CHRM2CHRM3OPRM1OPRL1POLB
SCHEMBL17606744 0.84 OPRM1 (0.43) CHRM2CHRM3OPRM1CYP2D6CYP3A4
SCHEMBL4536337 0.81 OPRM1 (0.52) CHRM2CHRM3OPRM1OPRL1POLB
SCHEMBL9179598 0.79 OPRL1 (0.51) OPRL1POLBCYP2D6CYP3A4TSHR
SCHEMBL9179579 0.78 HRH3 (0.49) OPRM1OPRL1POLBCYP2D6CYP3A4
SCHEMBL19307244 0.77 OPRM1 (0.47) CHRM2CHRM3OPRM1OPRL1POLB
SCHEMBL9179730 0.76 OPRL1 (0.49) OPRL1POLBCYP2D6CYP3A4TSHR
SCHEMBL9176072 0.75 OPRL1 (0.48) OPRL1POLBCYP2D6CYP3A4TSHR
SCHEMBL17606641 0.75 ACHE (0.50) OPRL1POLBMEN1KMT2A
SCHEMBL28437641 0.75 BCHE (0.43) CHRM2CHRM3OPRM1CYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194385-A1 N-(HETERO)ARYL-SUBSTITUTED HETEROYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES OR CONDITIONS RELATED TO THE CENTRAL NERVOUS SYSTEM Chronos Therapeutics Limited (GB) 2017-07-26 EP disclosed
WO-2016042453-A1 N-(HETERO)ARYL-SUBSTITUTED HETEROYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES OR CONDITIONS RELATED TO THE CENTRAL NERVOUS SYSTEM SHIRE INTERNATIONAL GMBH (CH) 2016-03-24 WO disclosed